DrugRisk Update: November Court Records Show Growing Pradaxa Lawsuits

Share Article

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

News Image
Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options.

The prescription drug resource center DrugRisk.com is announcing new information added to the site for patients taking the blood thinner Pradaxa. Recent court records show the number of lawsuits alleging the drug caused internal bleeding injuries has grown this month*.

The DrugRisk center was created to improve the safety of those taking popular prescription drugs by sharing the latest recalls, safety alerts, research and litigation news. Patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 to prevent blood clots and strokes in patients with atrial fibrillation. Experts disagree, however, about whether it increases risks of internal bleeding.

The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**. The Institute for Safe Medication Practices, however, has warned patients may be nearly five times as likely to die from Pradaxa bleeding than from warfarin***. A Dutch study this year also suggested patients taking blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

Due to the number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal multidistrict litigation court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugRisk has added the latest court records from the Judicial Panel on Multidistrict Litigation, which show the number of cases filed has increased from 1,643 on October 17 to 1,748 on November 18th, a rise of over 6% in a month*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisk.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Judicial Panel on Multidistrict Litigation, 11/18/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-November-18-2013.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
DrugRisk
+1 888-415-1859
Email >
Visit website